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Review article 
Ανασκόπηση
SUMMARY: Stem cells (SCs) are multipotent cells with differentiation and proliferation capacities in many cell 
lineages. The majority of literature applications are about bone marrow derived stem cells (BMSCs) and adipose de-
rived stem cells (ADSCs). Most clinical trials have been done for the treatment of musculoskeletal and neurological 
problems in canine patients. Hematopoietic SCs (HSCs), synovium (SDSCs) and cartilage (CSPCs) - derived SCs, 
umbilical cord blood-derived SCs (UCSCs), muscle, dental, cardiac and hepatic SCs have been used with promising 
results. Despite the overall progress crucial questions about SCs remain unanswered. It is still unclear if the regener-
ation mechanism of SCs owed to their differentiation into specific progenitor cells or due to their immunomodulatory 
and anti-inflammatory secretions. Also, there are questions about the best origin of stem cells, whether they should be 
delivered in situ or systemically, if they should be embedded into scaffolds or not and which is the suitable transplan-
tation stem cells number. Many of the published studies have limitation regarding to sample size, blind randomization, 
control groups and homogeneity of population. In addition,the long-term efficacy and safety of MSCs need further 
evaluation. This review is an update in usage of SCs, mainly focused on BMSCs and ADSCs in small animals and its 
purpose is to present the late developments in this field. Also, the advantages, the disadvantages and the limitations of 
the current literature review arediscussed.
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INTRODUCTION
Stem cells (SCs)are multipotent cells with differ-entiation and proliferation capacities in many 
cell lineages. They produce factors with immuno-
modalityand angiogenesis properties (Takemitsu et 
al., 2012). They divided intoembryonic SCs(ESCs) 
and adult mesenchymal SCs(MSCs). The latter can 
be harvested by mesodermal, endodermal or ectoder-
mal tissues (de Bakker et al., 2013). Depending on 
their origin they have advantages and limitations. For 
example, bone marrow - derived mesenchymal SCs 
(BMSCs) have the higher differentiation capacity in 
musculoskeletal cells, but their culture is time con-
suming (Fortier and Travis, 2011). Their osteogenic 
potential is better than adipose tissue - derived SCs 
(ADSCs) (Park et al., 2012), while the latterexhibit 
higher proliferation rate (Webb et al.,2011). Also, al-
logeneic versus autologous transplantation is still de-
batable (Zhang et al., 2015). In vitro studies proved 
that allogeneic transplantation is safe (Ryan et al., 
2005), due to a protective mechanism against T and 
B cells that forms a safe micro-environment (Ryan et 
al., 2005). Moreover, xenogeneic SCs transplantation 
was also presented. Human SCs promoted healing in 
dogs with bone defects (Cruz et al., 2015, Zang et al., 
2016), dermatological problems(Ferrer et al., 2015) 
andneurological diseases (Lee et al., 2009,Chung et 
al., 2013).
SCs usage in tissue engineering is a progressive 
technique that continues to expand increasingly in the 
veterinary world. Many scientific papers have been 
published over the last 10years (Arinzeh et al., 2003, 
Yan et al. 2007,Cui et al. 2007, Wang et al. 2014, 
Nantavisai et al., 2019, Voga et al. 2020).
ADVANCES IN STEM CELLS
Adipose tissue - derived stem cells (ADSCs)
Dogs
Musculoskeletal applications
In 2007, Cui et al. (2007) showed that autologous 
ADSCsenhanced bone regeneration in critical sized 
bone defects in canine models. Same conclusions re-
trievedfrom trials on mandibular (Haghighat et al., 
2011) and long bone defects (Bigham-Sadegh et al., 
2012). In 2013, Luiet al. repeated the same model 
with allogeneic ADSCs and presented similar results 
without adverse reactions (Liu et al., 2013). 
Τhe application of autologous ADSCs in coxofem-
oral (Black et al., 2007) and humeroradial joints with 
osteoarthritis (Black et al., 2008, Guercio et al., 2012) 
resulted in clinical improvement. Another study re-
inforced these results with kinetic force assessments 
(Vilar et al., 2014). Equally effective was the appli-
cation of allogeneic ADSCs (Harman et al., 2016). 
Moreover, the combination of autologous ADSCs 
with platelet-rich plasma (PRP) (Vilar et al., 2013, 
Cuervo et al., 2016, Yun et al., 2016) reduced pain in 
cases of osteoarthritis, but the studies lacked of con-
trol groups.
In 2014, an innovative administration of alloge-
neic ADSCs for hip dysplasia, in acupuncture points, 
showed clinical improvement (Marx et al., 2014). 
Also, promising was the administration of allogeneic 
ADSCs in elbow dysplasia (Kriston-Pal et al., 2017). 
Nevertheless, these studies did not present arthro-
scopic findings. Recently, another research demon-
strated that the local injection of ADSCs was superior 
compared to intravenous for degenerative arthritis 
(Shah et al., 2018). Unfortunately, the outcomes were 
based only on clinical evaluation.
ADSCs combined with PRP accelerated the recon-
struction of partial ruptured anterior cruciate ligament 
(Canapp et al., 2016a). In contrast, the use of ADSCs 
during tibial tuberosity advancement procedure did 
not diminish the healing time (Dos Santos et al., 2018). 
The results about ADSCs advantages were controver-
sial, but both studies had heterogeneous populations 
and different rehabilitation protocols. Furthermore, 
preliminary results proposed the combination of AD-
SCs with PRP for refractory supraspinatus tendinopa-
thy (Canapp et al. 2016b), semitendinosus myopathy 
(Gibson et al., 2017) and tracheal cartilage defects 
(Hashemibeni et al., 2012). Lastly, the combination of 
ADSCs with growth factor showed promising results 
in a canine tendon injury model (Sheh et al.,2018).
Neurological applications
ADSCs were used for spinal cord injury (SCI) 
(Roszek et al., 2016). Canine models investigated 
ADSCs capacities in situ (Ryu et al., 2009). Inter-
estingly, ADSCs promoted functional improvement 
after SCI (Park et al., 2012) and accelerated disk 
regeneration after disk degeneration disease (DDD)
(Ganey et al., 2009). However, the results were based 
on experimental conditions. In clinical field, two stud-
ies described the benefits of ADSCs transplantation 
in dogs with thoracolumbar DDD (Kim et al., 2016) 
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and peripheral (facial) nerve trauma (Ghoreishian et 
al., 2013). Both confirmed clinical improvement, but 
lacked of histopathological confirmation.
Dentistry and ophthalmology applications
ADSCs were used successfully in periodontal 
trauma (Tobita et al., 2013), atonic oral ulcers (Alam-
oudi et al., 2014) and as an osseointegration factor for 
dental implants (Bressan et al., 2015). To the authors’ 
knowledge, no clinical studies are currently available. 
After the proof of ADSCs safety inperiocular (Wood 
et al., 2012) and intra-lacrimal (Park et al., 2013) in-
jections, interest was concentrated in ADSCsusage 
against keratoconjunctivitis sicca (KCS) (Villatoro et 
al., 2015). Peri- and intra-lacrimal ADSCs transplan-
tation leaded to KCS remission (Bittencourt et al., 
2016). However, possible adverse reactions were not 
studied.
Other applications
The in vitro differentiation of ADSCs into cells 
similar to hepatocytes (Banas et al. 2007) triggered-
further studies. In one preclinical study, ADSCsde-
creased hepatic parameters after liver trauma (Teshi-
ma et al., 2017), and increased survival time in one 
dog with hepatocutaneous syndrome (Nam et al., 
2017). Also, ADSCs were employed for dogs with 
inflammatory bowel disease (Perez-Merino et al., 
2015). The conclusions are suggestive, as these stud-
ies lacked of long term efficacy and safety data. De-
spite the fact that ADSCs improve the cardiac func-
tion after myocardial infarction, clinical trials failed 
to prove their benefits in dilated cardiomyopathy (Po-
gue et al., 2013). A current comparison of ADSCs and 
BMSCs intrarenal injection in a canine renal injury 
model revealed better level of protection for ADCSs 
(Osman et al. 2020). Lastly, ADSCs application was 
beneficial for one dog with an atonic ulcer (Han et 
al., 2015) and another with pemphigus (Zubin et al., 
2014), but was not helpful for allergies (Hall et al., 
2010). 
Cats
One pilot study showed improvement in renal 
function in cats with chronic kidney failure after intra-
renal administration of autologous ADSCs (Quimby 
et al., 2011). However, the intravenous administration 
of allogeneic ADSCs was associated with adverse ef-
fects (Quimby et al., 2013). Further research in order 
to attempt tominimize these reactions failed (Quimby 
et al., 2016). The intravenous injection of ADSCs in 
cats with inflammatory bowel disease leaded to (Webb 
and Webb, 2015) signs remission. Also, the intraperi-
toneal injection of ADSCs was showed to be safe and 
possibly effective for various feline diseases (Parys 
et al., 2016). ADSCs were employed successfully in 
autoimmune diseases like gingivostomatitis (Arzi et 
al., 2016), asthma (Trzil et al., 2015) and eosinophilic 
keratitis (Villatoro et al., 2018). Nevertheless, larger 
sample sizes are needed to obtain more reliable re-
sults. 




The implantation of autologous BMSCs embed-
ded into various scaffolds, encouraged bone forma-
tion in alveolar (Kim et al., 2009), mandible (Hu et 
al., 2014), orbital (Yang et al., 2014) and long bone 
defects (Ozdal-Kurt et al., 2014). Also, the combi-
nation of cell sheet and scaffolds resulted in healing 
in mandible injuries (Shan and Hu, 2017). All the 
macroscopic results were co-evaluated with imaging 
and histological findings. Despite the fact that these 
were control studies and their results were significant 
different between groups, their sample sizes were 
limited. Few experimental works studied the impor-
tance of scaffolds and the migration of systemically 
administrated BMSCs. The intra-osseous injection of 
allogeneic BMSCs into femurs promoted bone regen-
eration in mandible defects (Liu et al., 2014). Similar 
were the results of intra-arterialinfusion of autologous 
BMSCs in dogs with femoral head necrosis (Jin et 
al., 2016). Both studies concluded that the technique 
was not only promising for bone density problems, 
but it was also safe. Moreover, genetic modification 
of BMSCs enhanced specific capacities. The induced 
expression of vascular endothelial growth factor 165 
(VEGF165) (Hang et al., 2012) or bone morphogenet-
ic protein -2 (BMP-2) (Peng and Wang, 2017) stim-
ulated the quantity and quality of new formed bone 
in femoral head osteonecrosis. These suggestions 
resulted from control-based studies with big sample 
sizes. Additionally, smaller studies concluded that 
microRNA-31 and dentin matrix protein-1 (DMP-1) 
manipulated BMSCs enhanced bone formation with 
superior features compared to simple BMSCs (Deng 
et al., 2014, Liu et al., 2016). BMSCs have also been 
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used for cartilage repair (Bornes et al., 2014). In 2005, 
Wayne et al. proposed that the injection of BMSCs 
in canine joints with articular defects promoted su-
perior quality of new formed cartilage. Concurrent-
ly, the outcomes from intralesional injection of bone 
marrow into traumatized meniscus, implied healing 
properties of BMSCs (Abdel- Hamid et al., 2005). 
Equivalent findings concluded from the intravenous 
and intrarticular injection of BMSCs, in dogs with 
partial cruciate ligament rupture, despite the limited 
sample and volume of synovial fluid available for 
tests (Muir et al., 2016). Following studies focused on 
PRP combination with BMSCs, because it improved 
their proliferation rate (Chen et al., 2014) and chon-
drogenetic capacity (Kazemi et al., 2017). A large ret-
rospective study suggested that their injection in dogs 
with supraspinatus tendinopathy resulted in clinical 
and ultrasonography improvement (McDougall et al., 
2018). However, there are no immunohistochemical 
assessments of these findings. Lastly, BMSCs were 
used successfully in tendon repair not only in vitro 
(Ozasa et al., 2014) but also in vivo (Case et al. 2013) 
and esophagus reconstruction (Tan et al., 2013). Nev-
ertheless, the data were preliminary. 
Neurological applications
BMSCs were also helpful for neurological dis-
orders (Kamishina et al., 2006). In 2008, Hiyama et 
al.(2008) investigated the intralesional autologous 
BMSCs injection in a canine model of DDD.The his-
tological and imaging analysis showed alteration of 
the micro-environment and inflammation’s inhibition 
(Hiyama et al., 2008). However, this was an exper-
imental model. Therefore, scientists investigated the 
safety of the procedure in clinical cases of DDD. 
Their results were controversial. One study present-
ed improvement of nociception and proprioception 
after autologous BMSCs transplantation (Besalti et 
al., 2015). Another study concluded that the proce-
dure may be safe, but not useful (Steffen et al., 2017). 
Both reports failed to make a statement due to limited 
samples and heterogenous populations. Furthermore, 
clinical results highlighted BMSCs efficacy after de-
compression surgery, in SCI (Nishida et al., 2012, 
Besaltiet al., 2016) even in chronic cases (Nishida et 
al., 2011). The improvement was similar after autolo-
gous or allogeneic BMSCs implantation (Jung et al., 
2009, Sarmento et al., 2014). Concurrently investi-
gation about the most suitable time for BMSCs ap-
plication (Penha et al., 2014) and the number of im-
planted cells (Serigano et al., 2010) was made. These 
parameters affected the outcomes, but no protocols 
were proposed. Recently, Wu et al. (2018) created a 
canine model with complete transection of spinal cord 
and presented that BMSCs could be beneficial even 
for devastating cases. Moreover, autologous BM-
SCs combined with scaffolds were used successfully 
in sciatic (Ding et al., 2010) and ulnar nerve defects 
(Kaizawa et al., 2016). Degeneration was accelerated 
functionally and histologically. Lastly, BMSCs were 
proposed for cases of autoimmune meningoenceph-
alomyelitis. Although the diagnosis was made by 
clinical examination, there was noted signs remission 
(Zeira et al., 2015).
Dentistry and ophthalmology applications
One report studied autologous BMSCs implanta-
tion into alveolar clefts combined with scaffolds, PRP 
and bone grafts (Yuanzhneng et al., 2015). The com-
bination of BMSCs with PRP showed the best results. 
The findings were equivalent to studies that support 
PRP’s proliferation properties in BMSCs (Chen et al., 
2014, Kazemi et al., 2017, McDougall et al. 2018). 
Another study proposed autologous, alveoral BMSC-
sas a different origin of BMSCs, due to their access 
and osteogenic potentials (Wang et al., 2018). Never-
theless, the conclusions were preliminary. Additional-
ly, large oral (Aly et al., 2014), vocal fold (Kanemaru 
et al., 2003) and laryngeal ulcers (Iravani et al., 2017) 
were favoured by the intra-lesional administration of 
autologous BMSCs. These results were supported by 
histological findings, but more research is needed. In 
veterinary ophthalmology experimental models of 
corneal ulcer (Tognoli et al., 2008) and retinal degen-
eration (Tracy et al., 2016), showed that autologous 
BMSCs were safe and anti- inflammatory. 
Other applications
Canine models of cirrhosis (Matsuda et al., 2017), 
renal trauma (Lim et al., 2016) and chronic enteritis 
(Xu et al., 2016) were usedinvestigate other effects. 
Autologous BMSCs improved function in liver fail-
ure, inhibited fibrosis in renal injuries and diminished 
clinical signs in post radiation enteritis (Xu et al., 
2016). Also, the usage of allogeneic BMSCs promot-
ed healing in cutaneous wounds without adverse ef-
fects (Kim et al., 2013). Furthermore, Memon et al. 
(2005) presented that the intra-lesional injection of 
BMSCs accelerated regeneration in ischemic myo-
cardium. Also, their intracoronary injection reduced 
infractions’ areas, confirmed by histology and immu-
nochemistry analysis (Hao et al., 2015). In the same 
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model, the adjunct of basic fibroblast growth factor 
augmented the engraftment and the differentiation of 
BMSCs (Wang et al., 2015). Undoubtedly, the previ-
ous studies had preliminary value and more research 
should be done in dosage, time points and administra-
tion routes. 
Cats
Feline BMSCs morphology and isolation are simi-
lar to human and rodents, (Martin et al., 2002, Zhang 
et al., 2011,Munoz et al., 2012) with higher neuro-
genic properties (Zhang et al., 2011). Also, c-kit+ fe-
line BMSCs differentiated into cardiac myocytes with 
cardiac action potentials (Kubo et al., 2009). How-
ever, feline BMSCs had culture limitations referred 
to the donor health status (Quimby et al., 2011). In 
vivo applications are few. A randomized clinical trial 
failed to demonstrate significant effect of BMSCs in 
acute kidney injury. Also, it left unanswered questions 
about the ideal routes, doses and frequency of BMSCs 
administration (Rosselli et al., 2016). Additionally, a 
case report of a cat with lumbar fracture that gained 
clinical rehabilitation after intraoperative BMSCs 
transplantation reinforced their beneficial effects in 
SCI (Penha et al., 2012).
Different tissue derived mesenchymal stem cells
Synovium (SDSCs) and cartilage (CSPCs) - de-
rived stem cells
SDSCs showed osteogenic capacity similar to 
BMSCs and rapid proliferation like ADSCs (Bearden 
et al., 2017). As referred to chondrogenic differenti-
ation, SDSCs were found to be superior to ADSCs 
and BMSCs (Sasaki et al., 2018). In fact, the intra-ar-
ticular injection of autologous SDSCs combined with 
hyaluronic acid in a canine model for cartilage repair, 
resulted in better macroscopic and histological scores 
compared to the control group (Miki et al., 2015). 
However, the studies lacked of statistical analysis. 
Until now, only autologous CSPCs harvested from 
ear cartilage showed capacity to regenerate both elas-
tic and hyaline chondral tissue (Mizuno et al., 2014). 
Muscle stem cells
Satellite cells become activated after trauma, as 
muscle precursor cells (MPCs). Satellite cells have 
high myogenic capacities, but they are no good candi-
dates for transplantation, because of harvesting, sur-
vival and migration problems. However, their good 
expanding and long term survival in vivo (Eberli et 
al.,2012) promoted their usage for functional regu-
lation of urinary sphincter (Eberli et al., 2012) and 
re-innervated thyroarytenoid muscle (Paniello et al., 
2018) in canine models. Histological analysis of both 
studies revealed the formation of new innervated 
muscle fibres. Muscle- derived stem cells (MDSCs) 
can be differentiated not only in myogenic, but also 
in other lineages, such as osteogenic, chondrogenic 
and tenocyte-like cells. In fact, MDSCs were superior 
compared to BMSCs for tendon repair (Ozasa et al., 
2014). Nevertheless, these findings were concluded in 
vitro. The majority of studies investigated MDSCs ef-
ficacy in dystrophic models. In 2011, a study proposed 
the intra-arterial administration of allogeneic MDSCs 
in dystrophic dogs to promote muscle regeneration 
(Rouger et al., 2011). Despite the limitation of small 
sample size, clinical and histopathological outcomes 
were favourable. Additionally, MDSCs were studied 
in molecular lever (Robriquet et al., 2015, Lardenois 
et al., 2016). Furthermore, a trial to make their us-
age easier showed that transient immunosuppression 
of the hosts was sufficient (Lorant et al., 2018). Un-
doubtedly, more research is needed about the immu-
nology features of MSDSs. 
Cardiac derived stem cells (CSCs)
Despite the fact that the majority of cardiac cells 
have not potentials to further differentiation, there is a 
population of CSCs with capacities to form myocytes 
and promote angiogenesis. In contrast to MSDSs, 
which could differentiate into muscle cells when in-
jected into the myocardium (Yoon et al., 1995), CSCs 
could enhance both cardiac regeneration and function 
by producing functional cardiac cells (Welt et al., 
2013, Taghavi et al., 2015). Autologous CSCs helped 
cardiac remodelling in infraction canine model (Welt 
et al., 2013) and improved cardiac function in feline 
cardiomyopathy model (Taghavi et al., 2015). How-
ever, in both studies the delivery method was invasive 
and new methods should be tried in order to make 
CSCs usage a possible clinical approach. 
Hepatic stem cells
Hepatic progenitor cells (HPCs) differentiated 
into hepatocytes and chollangiocytes (Kruitwagen et 
al., 2014). The activation, reaction and identification 
of HPCs were evaluated in normal dogs (Ijzer et al., 
2010) and cats (Ijzer et al., 2009). Also, HPCs were 
assessed in dogs with various liver diseases, such as 
acute and chronic hepatitis, cooper toxicosis, cancer 
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or biliary problems (Ijzer et al., 2010, Kruitwagen et 
al. 2019) and in cats with feline cholangitis (Otte et 
al., 2018) and lipidosis (Valtolina et al., 2018). De-
spite the fact that HPCs could be an alternative to 
liver transplant, which is no feasible in veterinary 
medicine, no current trials of HPCs usage have been 
reported. 
Dental pulp (DSCs), skin and hair follicle (HFSCs) 
stem cells
DSCs have high proliferation rate, easy accessi-
bility and differentiation potentials into many cell 
lineage (Ashiry et al., 2018). Autologous DSCs were 
used successfully in canine models for pulp regenera-
tion (Nakashima and Iohara, 2014, Chen et al., 2015, 
Ashiry et al., 2018) and periodontal healing (Khor-
sand et al., 2013). Also, allogeneic DSCs application 
was efficacious for periodontitis management (Iohara 
et al., 2018). Moreover, allogeneic DSCs were used 
indegenerative heart disease (Petchdee and Sompee-
wong, 2016) and xenogeneic (human) DSCs in SCI 
in dogs (Feitosa et al., 2017). Despite the promising 
results, both studies lacked histological and imaging 
assessments. Also, periodontal stem cells (PDLSCs) 
were isolated as another tool for periodontitis therapy, 
but the studies were in vitro (Khoshhal et al., 2017). 
To the authors’ knowledge skin and hair follicle stem 
cells were identified and characterized in dogs (Bra-
chelente et al., 2013), but they have not been used in 
vivo. 
Umbilical cord blood-derived stem cells (UCSCs)
UCSCs exhibit less immunogenicity, higher plas-
ticity and production of cells per volume compared to 
MSCs (Jin et al., 2008).UCSCs were used mainly in 
SCI models (Lim et al., 2007, Park et al. 2011, Ryu 
et al. 2012) in order to promote clinical improvement 
and regulate inflammation (Park et al., 2011). How-
ever, histopathology and imaging evidence is needed 
(Lim et al., 2007, Ryu et al., 2012).
Hematopoietic stem cells (HSCs)
HSCs originate from bone marrow,umbilical cord 
and peripheral blood. HSCs form lymphoid and my-
eloid progenitor cells (Gomes et al., 2017). In 1962 
and 1974, bone marrow transplantation in dogs im-
plied its benefits (Thomas et al.,1962,Epstein et al., 
1967, Dale and Graw, 1974). Later, studies used au-
tologous hematopoietic stem cells transplantation 
(HSCT), against auto-immune diseases (Stolfi et al., 
2016). Also, allogeneic HSCT was employed in the 
modification of host-versus-graft reaction (Zorn et 
al., 2011, Mathes et al., 2014, Vrecenak et al., 2014, 
Rosinski et al., 2015). Interestingly, allogeneic HSCT 
improved hosts’ tolerance towards skin allografts, by 
T-cells regulation (Mathes et al., 2014). The first clin-
ical case of allogeneic HSCT was completed in a dog 
with lymphoma (Lupu et al., 2006). Then, two stud-
ies tried autologous HSCT for lymphoma (Escobar 
et al., 2012, Willcox et al., 2012) and acute leukemia 
(Suter et al., 2015). All agreed that HSCT increased 
the duration of signs remission. However, according 
to Schaefer et al. (2016) allogeneic HSCT had prob-
lems related to HSCs ability to reach bone marrow 
without being trapped in other tissues. Lange at al. 
(2017) tried to identify the best route of administra-
tion by comparing the intravenous and intraosseous 
HSCT. However, the study failed to prove superiority 
of one method over the other. Few are known about 
feline HSCs, which have similar proliferative capaci-
ties to canine (Abkowitz et al., 1993, Abkowitz et al., 
1995). Feline HSCs were used after genetical manip-
ulation for inhibition of coronavirus replication and 
development of feline infectious peritonitis (Anis et 
al., 2017). 
CONCLUSIONS
In conclusion, literature review cannot still an-
swer questions regardingthe best origin ofSC, the 
most suitable route of administration, whether they 
should be embedded into scaffolds or notas well as 
which is the ideal number of transplanted cells. Also, 
it remains unanswered if the therapeutic potentials of 
SCs exist due to their differentiation into progenitor 
cells or due to their immunomodulatory secretions. 
Many experimental models are used for preliminary 
data, while the clinical use of SCs is in early stages. 
Most of these studies focused on the usage of BMSCs 
and ADSCs, because of their easy collection and cul-
ture, their sufficient differentiation capacity in muscu-
loskeletal cells and high proliferation rate. However 
published data have limitations because of their small 
sample size, heterogeneity of population, lack of blind 
randomization and control groups. Therefore, a future 
research plan should involve methods and techniques 
capable to collect answers for all these questions. 
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